Page last updated: 2024-08-24

triazoles and Hypokalemia

triazoles has been researched along with Hypokalemia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, D; McHardy, I; Semrad, A; Thompson, GR; Wittenberg, RR1
Greene, M; Harris, B; Kuriakose, K; Nesbitt, WJ1
McKinnon, M; Reimer, EK; Stock, W; Wassermann, T1
Bagatell, R; Bosse, KR; Fisher, BT; Martino, J1
Bapat, A; Cao, H; Eskandari, A; Karagueuzian, HS; Ko, CY; Nguyen, T; Nivala, M; Pezhouman, A; Qu, Z; Singh, N; Song, Z; Weiss, JN1
Abu Saleh, O; Mahmood, M; Sohail, MR1
Alvarez Tundidor, S; González Rozas, M; Pineda Alonso, M1
Estes, LL; Wilson, JW; Zeuli, JD1
Kidd, D; Morris, TC; Ranaghan, EA1

Other Studies

9 other study(ies) available for triazoles and Hypokalemia

ArticleYear
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aged; Antifungal Agents; Cortisone; Humans; Hydrocortisone; Hypertension; Hypokalemia; Lung; Male; Mineralocorticoid Excess Syndrome, Apparent; Pulmonary Aspergillosis; Triazoles

2017
Posaconazole-Induced Pseudohyperaldosteronism.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Aged; Antifungal Agents; Heart Failure; Histoplasmosis; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Excess Syndrome, Apparent; Triazoles; Voriconazole

2018
Refractory Hypokalemia from Syndrome of Apparent Mineralocorticoid Excess on Low-Dose Posaconazole.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:7

    Topics: Aged; Female; Humans; Hypokalemia; Leukemia, Myeloid, Acute; Mineralocorticoid Excess Syndrome, Apparent; Potassium; Triazoles

2018
Suspected posaconazole toxicity in a pediatric oncology patient.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:9

    Topics: Adolescent; Anorexia; Antifungal Agents; Combined Modality Therapy; Delayed-Action Preparations; Drug Therapy, Combination; Fatigue; Female; Humans; Hypokalemia; Maxillary Sinus Neoplasms; Medication Errors; Musculoskeletal Pain; Mycoses; Osteosarcoma; Postoperative Complications; Sinusitis; Triazoles

2015
Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation.
    Circulation, 2015, Oct-20, Volume: 132, Issue:16

    Topics: Action Potentials; Animals; Benzylamines; Computer Simulation; Hypokalemia; Male; Phenethylamines; Pyridines; Rabbits; Rats; Rats, Inbred F344; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Triazoles; Ventricular Fibrillation

2015
Hypokalemia and Hypertension Associated with Supratherapeutic Posaconazole Levels.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Antifungal Agents; Histoplasmosis; Humans; Hypertension; Hypokalemia; Lymphoma, Large B-Cell, Diffuse; Male; Mycoses; Triazoles

2017
Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:1

    Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Drug Therapy, Combination; Humans; Hypokalemia; Linezolid; Lung Diseases, Fungal; Male; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Potassium Chloride; Pyrimidines; Triazoles; Voriconazole

2011
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole

2013
Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole.
    Lancet (London, England), 1989, May-06, Volume: 1, Issue:8645

    Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Hypokalemia; Leukemia, Myeloid, Acute; Triazoles

1989